AzTrials
AzTrials

Type 2 DiabetesJAC_ARSNCT07783893

E-Health Literacy Intervention for Bangladeshi Migrants With Type 2 Diabetes in Italy

An observational study of Type 2 Diabetes and Diabete Mellitus, run by Marche Region Regional Health Agency at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study is testing a training program for people from the Bangladeshi community of Ancona in the Marche Region (Italy) who have type 2 diabetes. Many people in this group find it hard to understand health information, including how to use digital health tools. This is called low health literacy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Type 2 Diabetes, Diabete Mellitus
What is being tested?
Culturally Adapted eHealth Literacy Training Program
How many people
50 participants
Where
1 siteItaly
Study dates
10 Mar 2025to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults of Bangladeshi ethnicity with type 2 diabetes mellitus, residing in the Marche Region (Italy) and followed by the diabetes center (Centro Antidiabetico, CAD) of the University Hospital of the Marche Region (Azienda Ospedaliero-Universitaria delle Marche) in Ancona. Participants are recruited from among patients already in active follow-up at this clinic who wish to take part in the study and meet the eligibility criteria, including sufficient Italian language proficiency (CEFR level A2 or above), preserved cognitive status, absence of severe depressive symptoms, and low levels of health literacy, eHealth literacy, or self-efficacy in diabetes management. The Bangladeshi community is one of the largest ethnic minority groups in the Marche Region.

Who may be able to join

  • belonging to Bangladesh ethnicity
  • affected by DM type 2 (as confirmed by the physician's diagnosis)
  • Followed by the CAD of the capital province of Marche Region, Ancona, located in Azienda Ospedaliero Universitaria delle Marche
  • aged >= 18 years old
  • Capable of communicating verbally in local language (corresponding to a level of Italian language knowledge =>A2-CEFR level) (Council of Europe, 1996)
  • without acute medical problems: myocardial infarction or stroke within 6 months, painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility, advanced Parkinson's disease and/or neuromuscular disorders, metastatic cancer, or immunosuppressive therapy, significant visual or hearing impairment, uncontrolled hypertension or other serious conditions that restrict their participation in the study.
Show all 11Show fewer
  • MMSE>= 24 (Folstein et al. 1975)
  • PHQ-9=< 15 (Kroenke et al. 2001)
  • with a low HL level, assessed by a scoring <=12 of HLS-EU-Q16 (Pelikan et al. 2017) and/or with low e-HL level, measured through e-HEALS (Norman \& Skinner, 2006-II), assessed by a scoring <=29, and/or with low levels in self-efficacy, measured IT-DMSES (Messina et al. 2018), assessed by a scoring <4.
  • capable to consent
  • fulfilling the informed consent.

Who cannot join

  • Failure to meet the inclusion criteria;
  • Concomitant participation in other studies;
  • Lack of written informed consent.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Azienda Ospedaliero Universitaria delle Marche (AOU Marche)

    Ancona, March, 60126

Other trials in Italy

About this study

Official title: JACARDI: Intervention to Support E-health Literacy of People Belonging to the Bangladesh Ethnic Minority Affected by Diabetes Mellitus Type 2: an Italian Pilot Study

This study is testing a training program for people from the Bangladeshi community of Ancona in the Marche Region (Italy) who have type 2 diabetes. Many people in this group find it hard to understand health information, including how to use digital health tools. This is called low health literacy. Low health literacy can make it harder to manage diabetes well.

The goal of this study is to find out if the training program improves health literacy and confidence in managing diabetes.

Read more

About 50 adults with type 2 diabetes from the Bangladeshi community are taking part. They are followed by the diabetes clinic at the University Hospital of the Marche Region in Ancona.

Before training started, patients, caregivers, and health workers helped design the program together. This made sure the training fit the community's needs and culture.

Participants complete a training program with four short modules. The modules cover diabetes, health literacy, and digital skills for managing diabetes.

Researchers measure health literacy, digital skills, and confidence in managing diabetes before training, right after training, and again after 1 month and 6 months. This shows whether the improvements last over time.

This study is part of JACARDI, a European project working to reduce diabetes and heart disease across Europe.

Read the detailed description

This is a monocentric pilot study conducted within the JACARDI (Joint Action on CARdiovascular diseases and Diabetes) framework, Grant Agreement ID 101126953, whose general objective is to reduce the burden of cardiovascular disease and diabetes across EU countries by integrating validated best practices through transnational pilot initiatives. The study is led by the Regional Health Agency of the Marche Region (Italy), in collaboration with the diabetes center (Centro Antidiabetico, CAD) of the University Hospital of the Marche Region (Azienda Ospedaliero-Universitaria delle Marche) in Ancona.

Type 2 diabetes mellitus (DM) is a growing global health burden, and glycaemic control is a central therapeutic goal that depends heavily on patients' self-management abilities. Self-management capacity, in turn, is strongly related to individual health literacy (HL) - the ability to obtain, process, and understand basic health information - and eHealth literacy (e-HL), the ability to find, evaluate, and apply electronic health information to health problems. People with low HL and e-HL tend to have poorer health outcomes, higher hospitalization and mortality rates, and reduced ability to self-manage chronic conditions. These risks are amplified in ethnic minority populations facing linguistic and social barriers. The Bangladeshi community is one of the largest foreign populations in the Marche Region and, as part of the Asian population, is at elevated risk of type 2 DM as well as low HL and e-HL. Evidence indicates that structured, culturally oriented educational programs, delivered by trained healthcare professionals and involving peer support, are effective in improving self-management and glycaemic control, and that early, sustained involvement of stakeholders in intervention design improves implementation outcomes and long-term sustainability.

The study follows the OPHELIA (OPtimising HEalth Literacy and Access) methodology, which combines local community engagement with international evidence to co-design, develop, and implement health literacy interventions that are accessible, culturally appropriate, and sustainable. The study is structured in two main phases: a pre-study (co-design) phase and a core intervention phase.

The pre-study phase involves a situation analysis conducted using the Consolidated Framework for Implementation Research (CFIR) and PESTEL (Political, Economic, Social, Technological, Environmental, Legal) tools to identify enablers of and barriers to implementation, through one online and one in-person stakeholder meeting; and two focus groups with patients and their family/community members supported by a cultural mediator, to assess healthcare service accessibility, evaluate the appropriateness of the planned training content, and gather input on perceived barriers and enablers to using digital health tools. These focus groups used co-design techniques and were analyzed qualitatively. Educational materials - brochures and digital tools including videos - were developed drawing on the ACCESS training program, materials used in clinical routine, and validated guidelines from the Ministry of Health and diabetes scientific societies, then translated and culturally adapted into Italian and Bengali and made available to participants.

Approximately 50 participants are organized into 4 training sessions of 10 participants each. Each session comprises 4 modules delivered in person at the CAD of Ancona, combining didactic and interactive methods, with support from a cultural mediator and diabetic peers:

Module I: Awareness of DM type II, and core principles of HL and e-HL Module II: Digital health skills, part I - use of health apps and digital tools Module III: Digital health skills, part II - usability of technological devices and online health services Module IV: Self-evaluation of acquired knowledge and skills, and assessment of program sustainability and satisfaction

Data are collected at four time points - baseline (T0, before training), post-intervention (T1, at the end of the training), 1-month follow-up (T2), and 6-month follow-up (T3) - using validated, self-administered, paper-based questionnaires, together with clinical assessment. Assessed domains include eHealth literacy, health literacy, self-efficacy in diabetes management, social integration and support, quality of life, DM severity and related clinical parameters, diabetes-related emotional distress, and participants' perceived satisfaction with the training.

Continuous variables are reported as mean and standard deviation or median and interquartile range depending on distribution (assessed via Kolmogorov-Smirnov test); categorical variables as absolute numbers and percentages. Pre- and post-intervention comparisons use paired t-tests or Wilcoxon matched-pairs signed-rank tests for continuous outcomes, and Mann-Whitney U or Chi-square tests as appropriate. Analyses are performed using STATA or R.

This study poses minimal risk to participants. Personal data are processed in anonymous, aggregate form in accordance with EU Regulation 2016/679 (GDPR) and Italian Legislative Decree No. 101/2018.

Being tested
Culturally Adapted eHealth Literacy Training Program
Keywords
eHealth literacy, Health literacy, Type 2 diabetes mellitus, Ethnic minority, Migrant health, Bangladeshi community, Culturally tailored education, Community-based participatory research, Equity
Medical subject headings
Diabetes Mellitus, Type 2, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Culturally Adapted eHealth Literacy Training ProgramBehavioural

    A structured, culturally adapted educational intervention aimed at improving eHealth literacy, health literacy, and self-management skills in Bangladeshi patients with type 2 diabetes. The training was co-designed with patients, family/community members, and healthcare stakeholders during a preparatory phase, based on the OPHELIA methodology and the ACCESS training model. It consists of 4 modules delivered in person at the diabetes center over 8 weeks (1 module every 15 days, approximately 120 minutes each), combining didactic teaching and interactive/practical sessions, with the support of a cultural mediator and diabetic peers. Topics include: type 2 diabetes awareness and management; principles of health literacy and eHealth literacy; use of digital health apps and tools; usability of technological devices and online health services; and self-evaluation of acquired knowledge and skills.

Study groups in NCT07783893
Study groupRoleWhat they receive
Bangladeshi patients with type 2 diabetes receiving the eHealth literacy trainingAdults of Bangladeshi ethnicity with type 2 diabetes mellitus, followed by the diabetes center (CAD) of the University Hospital of the Marche Region in Ancona, meeting the study eligibility criteria. Participants receive a culturally adapted health literacy and eHealth literacy training intervention, co-designed with patients, family/community members, and healthcare stakeholders during a preparatory phase. The intervention consists of 4 modules delivered in person over 8 weeks (1 module every 15 days, approximately 120 minutes each), combining didactic and interactive methods with the support of a cultural mediator and diabetic peers. Modules cover: awareness of type 2 diabetes, health literacy and eHealth literacy principles; digital health tools and apps; usability of technological devices and online health services; and self-evaluation of acquired skills. Outcomes are assessed at baseline, post-intervention, and at 1- and 6-month follow-up.
Receives: Behavioral: Culturally Adapted eHealth Literacy Training Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement of ehealth literacy among Bangladeshi type 2 diabetes patients

    eHealth literacy will be assessed using the eHealth Literacy Scale (eHEALS), an 8-item measure of consumers' combined knowledge, comfort, and perceived skills in finding, evaluating, and applying electronic health information to health problems. The scale assesses the ability to access and use internet health information (items 1-5), judgment ability (items 6-7), and decision-making ability (item 8). Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree), with total scores ranging from 8 to 40; higher scores indicate greater eHealth literacy. The scale will be administered as a self-reported, paper-based tool, with support from a cultural mediator when needed, at baseline, at the end of the training intervention, and at 1-month and 6-month follow-up.

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

Secondary outcomes (11)
  1. Improvement of health literacy levels among paticipants

    Health literacy will be assessed using the 16-item European Health Literacy Survey Questionnaire (HLS-EU-Q16), which measures health literacy across three domains: healthcare, disease prevention, and health promotion. Each item is answered by choosing one of four response options: "very difficult," "fairly difficult," "fairly easy," or "very easy." The questionnaire will be administered as a self-reported, paper-based tool, with support from a cultural mediator when needed, at baseline, at the end of the training intervention, and at 1-month and 6-month follow-up, to evaluate change over time.

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  2. Improvement of Self-Efficacy in Diabetes Management (IT-DMSES)

    Self-efficacy in diabetes management will be assessed using the Italian Diabetes Management Self-Efficacy Scale (IT-DMSES). The scale consists of 15 items divided into two factors: Factor 1, self-efficacy in diabetes management (e.g., medication adherence, glycaemic control), and Factor 2, self-efficacy in lifestyle management (e.g., eating behaviors, physical activity). Each factor score ranges from 0 to 10, with higher scores indicating greater self-efficacy (low: 0-3; mid: 4-6; high: 7-10). The scale will be administered as a self-reported, paper-based questionnaire, with support from a cultural mediator when needed, at baseline, at the end of the training intervention, and at 1-month and 6-month follow-up, to evaluate change over time.

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  3. Improvement of Perceived Social Support and Integration (MSPSS)

    Perceived social support and integration will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item self-reported questionnaire measuring perceived adequacy of social support from three sources: family, friends, and significant others. Each item is rated on a 5-point Likert scale ranging from 0 (strongly disagree) to 5 (strongly agree). The questionnaire will be administered as a self-reported, paper-based tool, with support from a cultural mediator when needed, at baseline and at 1-month follow-up, to evaluate change over time.

    Measured: Baseline (T0) and 1-month follow-up (T2)

  4. Improvement of Quality of Life (EQ-5D-5L VAS)

    Quality of life will be assessed using the EQ-5D-5L Visual Analogue Scale (VAS). The EQ-5D-5L consists of five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression - each rated across 5 severity levels (no problems, slight, moderate, severe, extreme problems). Participants indicate their health status by selecting the most appropriate level for each dimension, and additionally rate their overall health on the VAS, a vertical scale from 0 (worst imaginable health) to 100 (best imaginable health). The questionnaire will be administered as a self-reported, paper-based tool, with support from a cultural mediator when needed, at baseline, at the end of the training intervention, and at 1-month and 6-month follow-up, to evaluate change over time.

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  5. Reduction of Diabetes-Related Emotional Distress (PAID)

    Diabetes-related emotional distress will be assessed using the Problem Areas in Diabetes (PAID) questionnaire, a 20-item self-report scale measuring negative emotions related to diabetes (e.g., fear, anger, frustration). Each item is rated on a 5-point scale from 0 ("no problem") to 4 ("a serious problem"). The questionnaire will be administered as a self-reported, paper-based tool, with support from a cultural mediator when needed, at baseline, at the end of the training intervention, and at 1-month and 6-month follow-up, to evaluate change over time.

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  6. Perceived utility, efficacy and effectiveness of the training (ad hoc questionnaire)

    Participants' experience with the training will be assessed using an ad hoc, self-reported questionnaire developed specifically for this study, based on the target group and training modules. The questionnaire collects information on participants' overall satisfaction, perceived usefulness and effectiveness of the training, any benefits or limitations experienced, and suggestions for improvement. It will be administered as a paper-based tool, with support from a cultural mediator when needed, at the end of the training intervention.

    Measured: End of intervention, at 8 weeks (T1)

  7. To evaluate the changes, after the intervention, in T2DM severity, through clinical records/physician visits.

    This outcome will be assessed evaluating the change in the levels of Serum total cholesterol (mg/dl), triglycerides (mg/dl), High-Density Lipoproteins (mg/dl) and Low-Density Lipoproteins cholesterol (mg/dl).

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  8. To evaluate the changes, after the intervention, in T2DM severity, through clinical records/physician visits.

    This outcome will be assessed evaluating the change in waist circumference (cm)

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  9. To evaluate the changes, after the intervention, in T2DM severity, through clinical records/physician visits.

    This outcome will be assessed through evaluating the body weight (kg).

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  10. To evaluate the changes, after the intervention, in T2DM severity, through clinical records/physician visits.

    This outcome will be assessed evaluating the change Body Mass Index (BMI) (kg/m^2).

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

  11. To evaluate the changes, after the intervention, in T2DM severity, through clinical records/physician visits.

    This outcome will be assessed evaluating the change in the levels of glycated haemoglobin (HbA1c) - (mmol/mol)

    Measured: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2026
  2. Study start10 Mar 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07783893
Sponsor's protocol ID
3736
Acronym
JAC_ARS
Status last verified
Aug 2026
First submitted
14 Aug 2026
Last updated
25 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Type 2 Diabetes and Diabete Mellitus, run by Marche Region Regional Health Agency at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement of ehealth literacy among Bangladeshi type 2 diabetes patients (time frame: Baseline (T0), end of intervention at 8 weeks (T1), 1-month follow-up (T2), and 6-month follow-up (T3)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in